000			02068 a2200553 4500
005			20250516073945.0
264		0	_c20120427
008			201204s 0 0 eng d
022			_a1872-7980
024	7		_a10.1016/j.canlet.2011.12.043 _2doi
040			_aNLM _beng _cNLM
100	1		_aFujimaki, Shun
245	0	0	_aBlockade of ataxia telangiectasia mutated sensitizes hepatoma cell lines to sorafenib by interfering with Akt signaling. _h[electronic resource]
260			_bCancer letters _cJun 2012
300			_a98-108 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aAtaxia Telangiectasia Mutated Proteins
650	0	4	_aBenzenesulfonates _xtherapeutic use
650	0	4	_aCaffeine
650	0	4	_aCarcinoma, Hepatocellular _xdrug therapy
650	0	4	_aCell Cycle Proteins _xantagonists & inhibitors
650	0	4	_aCell Line, Tumor
650	0	4	_aDNA-Binding Proteins _xantagonists & inhibitors
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aDrug Synergism
650	0	4	_aHumans
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aPhenylurea Compounds
650	0	4	_aProtein Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aPyridines _xtherapeutic use
650	0	4	_aRNA, Small Interfering
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSorafenib
650	0	4	_aTumor Suppressor Proteins _xantagonists & inhibitors
700	1		_aMatsuda, Yasunobu
700	1		_aWakai, Toshifumi
700	1		_aSanpei, Ayumi
700	1		_aKubota, Masayuki
700	1		_aTakamura, Masaaki
700	1		_aYamagiwa, Satoshi
700	1		_aYano, Masahiko
700	1		_aOhkoshi, Shogo
700	1		_aAoyagi, Yutaka
773	0		_tCancer letters _gvol. 319 _gno. 1 _gp. 98-108
856	4	0	_uhttps://doi.org/10.1016/j.canlet.2011.12.043 _zAvailable from publisher's website
999			_c21480747 _d21480747